Combination therapy in vitiligo
Phase 2
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT2016061527802N2
- Lead Sponsor
- Vice Chancellor of Research, Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
diagnosis of facial vitiligo
Exclusion criteria: history of alopecia areatea; diabetes; Addison's disease; pernicious anemia; Graves disease; Hashimoto’s thyroiditis; systemic lupus erythematosus; history of treatment with NB-UVB in the past two weeks; history of applying topical medications in the past 2 weeks prior to the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Repigmentation. Timepoint: Every month. Method of measurement: Objective evaluation by two blinded Dermatologists.
- Secondary Outcome Measures
Name Time Method Patients satisfaction. Timepoint: After four months. Method of measurement: Objective score given by the patient on a scale of 0-10.;Side effects of the treatment. Timepoint: Every month. Method of measurement: History taking and physical examination.